Legal Issues

Johnson & Johnson shareholders unhappy with management

A story in the Washington Post says that several Johnson & Johnson shareholders spoke of their dissatisfaction with the company during their annual meeting recently. Their complaints focused on a long string of product recalls, ethical lapses and excessive executive pay.

In 2010, the company’s McNeil Consumer Healthcare unit recalled more than 280 million packages of over-the-counter medications, which included Motrin, children’s Tylenol liquid and Benadryl.

Also in 2010, Johnson & Johnson’s ...

continue reading...

Israeli doctors cautioned about diabetes medication

An article in the Jerusalem Post says the Israeli Health Ministry’s pharmaceutical division is cautioning doctors to be vigilant for cases of pancreatic infections and pancreatic cancer among people taking a class of diabetes drugs that includes Byetta and Januvia.

The story says the announcement followed similar warnings by both the U.S. Food and Drug Administration and its European counterpart about the drugs.

A number of studies have linked both Byetta and ...

continue reading...

FDA approves new cholesterol medication

Nature World News reports that the U.S. Food and Drug Administration has approved the anti-cholesterol drug Liptruzet.

According to the story, Liptruzet is a combination of Merck’s Zetia, which lowers low-density lipoprotein (LDL), and a generic version of Pfizer’s Lipitor, which lost its patent protection in 2011.

Lipitor has recently generated some health concerns.

The U.S. Food and Drug Administration has added warnings to Lipitor’s label, advising that the medication may increase the ...

continue reading...

Analysis says diabetes drugs carry risks

Diabetes

A report on FiercePharma says an analysis by safety watchdog group Institute for Safe Medication Practices found the class of diabetes drugs that includes Merck’s Januvia and Bristol-Myers’s Byetta may increase the risk for pancreatitis and pancreatic cancer.

The analysis found that reports of pancreatitis (an inflammation of the pancreas) and pancreatic cancer were about 25 percent higher for the class of drugs known as GLP-1, compared to older treatments.

FiercePharma notes ...

continue reading...

Plaintiff in mesh case supports European patients

An American plaintiff awarded $11.1 million in court because of her injuries from a vaginal mesh implant is lending her support to women seeking similar legal redress in Scotland and the U.K., according to a story in the Scots paper Daily Record.

The story says scores of women in Scotland have also suffered ill effects from the devices, implanted to treat pelvic organ prolapse and urinary incontinence.

The ...

continue reading...

Mesh implants injure women in Scotland

A story in the Daily Record out of Scotland deals with the plight of Scots women injured after receiving vaginal mesh implants. Hundreds may be “suffering horrendous health problems” from the devices, which are implanted to treat urinary incontinence and pelvic organ prolapse.

The story notes that the implants have generated widespread complaints in the United States of causing health problems for patients who receive them.

“The recognized ...

continue reading...
Page 10 of 64 «...89101112...»